Global
About Us
Company Profile
Milestones
Core Team
Science and Technology
Research Field
Technology Platform
Product Pipeline
Manufacturing Plants
Intellectual Property Rights
Investor Relations
Company Information
Financial Reports
Announcements and Circulars
Corporate Governance
News Centre
Company News
Media Coverage
Join Us
Corporate Culture
Business Outlook
Benefits
Job Opportunities
Contact us
Shanghai
Beijing
Overseas
INVESTOR RELATIONS
Company Information
Financial Reports
Announcements and Circulars
Corporate Governance
Announcements and Circulars
Year
2023
2022
2021
2020
2019
2018
Month
01
02
03
04
05
06
07
08
09
10
11
12
2023-09-29
DISCLOSEABLE TRANSACTION DISPOSAL OF 15% EQUITY INTEREST IN AN ASSOCIATE
2023-09-22
2023 Interim Report
2023-09-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
2023-08-25
POLL RESULTS OF THE 2023 FIRST EXTRAORDINARY GENERAL MEETING HELD ON AUGUST 25, 2023
2023-08-25
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
2023-08-15
NOTICE OF BOARD MEETING
2023-08-09
PROXY FORM FOR USE AT THE 2023 FIRST EXTRAORDINARY GENERAL MEETING
2023-08-09
NOTICE OF THE 2023 FIRST EXTRAORDINARY GENERAL MEETING
2023-08-09
PROPOSED EXTENSION OF THE VALIDITY PERIOD OF THE RESOLUTIONS CONCERNING THE PROPOSED ISSUE OF A SHARES AND LISTING ON THE SCI-TECH BOARD, PROPOSED EXTENSION OF THE VALIDITY PERIOD OF THE RESOLUTION AUTHORIZING THE BOARD OF DIRECTORS AND PERSONS AUTHORIZED BY IT TO FULLY HANDLE THE RELEVANT MATTERS IN CONNECTION WITH THE ISSUE OF A SHARES AND LISTING ON THE SCI-TECH BOARD AND NOTICE OF EGM
2023-08-04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
2023-08-01
ARTICLES OF ASSOCIATION
2023-08-01
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
2023-07-11
PROPOSED EXTENSION OF THE VALIDITY PERIOD OF THE RESOLUTIONS CONCERNING THE ISSUE OF A SHARES AND LISTING ON THE SCI-TECH BOARD AND OTHER ANCILLARY RESOLUTIONS AND CLOSURE OF REGISTER OF MEMBERS
2023-07-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
2023-06-15
POLL RESULTS OF THE 2022 ANNUAL GENERAL MEETING AND CLASS MEETINGS HELD ON JUNE 15, 2023
2023-06-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
2023-05-24
Proxy Form for the 2023 First Class Meeting of Domestic Shareholders
2023-05-24
Proxy Form for the 2023 First Class Meeting of H Shareholders
2023-05-24
Proxy Form for the Annual General Meeting to be held on June 15 2023
2023-05-24
(1) 2022 REPORT OF THE BOARD OF DIRECTORS (2) 2022 REPORT OF THE BOARD OF SUPERVISORS (3) 2022 ANNUAL REPORT (4) 2022 FINANCIAL ACCOUNTS REPORT (5) 2023 FINANCIAL BUDGET (6) 2022 ANNUAL PROFIT DISTRIBUTION PLAN (7) RE-APPOINTMENT OF AUDITOR (8) PROPOSED AMENDMENTS TO ARTICLES IN RESPECT OF TRIAL MEASURES (9) PROPOSED AMENDMENTS TO ARTICLES IN RESPECT OF PROPOSED ISSUE OF A SHARES (10) GENERAL MANDATE TO ISSUE ADDITIONAL SHARES AND NOTICES OF THE 2022 ANNUAL GENERAL MEETING AND THE CLASS MEETINGS
2023-05-24
NOTICE OF THE 2023 FIRST CLASS MEETING OF DOMESTIC SHAREHOLDERS
2023-05-24
NOTICE OF THE 2023 FIRST CLASS MEETING OF H SHAREHOLDERS
2023-05-24
NOTICE OF THE 2022 ANNUAL GENERAL MEETING
2023-05-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
2023-04-26
CLOSURE OF REGISTER OF MEMBERS FOR ANNUAL GENERAL MEETING TO BE HELD ON JUNE 15, 2023
2023-04-26
Terms of Reference for Remuneration and Appraisal Committee
2023-04-26
2022 Annual Report
2023-04-04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
2023-03-17
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
2023-03-06
NOTICE OF BOARD MEETING
2023-03-02
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
2023-02-23
INSIDE INFORMATION ANNOUNCEMENT EXCLUSIVE LICENSE AGREEMENT WITH ASTRAZENECA FOR CMG901
2023-02-05
VOLUNTARY ANNOUNCEMENT UPDATE ON THE DATA FROM PHASE Ia CLINICAL STUDY OF CMG901 PRESENTED AT THE 2023 ASCO GI CANCERS SYMPOSIUM
2023-02-02
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
2023-01-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
2022-12-02
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
2022-11-01
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
2022-10-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022
2022-09-29
VOLUNTARY ANNOUNCEMENT CONDITIONAL MARKETING APPROVAL OBTAINED IN CHINA FOR PUYOUHENG (PUCOTENLIMAB INJECTION) FOR THE TREATMENT OF INOPERABLE OR METASTATIC MELANOMA
2022-09-29
VOLUNTARY ANNOUNCEMENT BREAKTHROUGH THERAPY DESIGNATION GRANTED BY THE CDE TO MRG003 FOR THE TREATMENT OF R/M NPC
2022-09-27
2022 Interim Report
2022-09-23
(1) POLL RESULTS OF THE POSTPONED EGM AND POSTPONED CLASS MEETINGS HELD ON SEPTEMBER 23, 2022 AND (2) AMENDMENTS TO THE ARTICLES OF ASSOCIATION, THE RULES OF PROCEDURES FOR THE MEETING OF SHAREHOLDERS, THE RULES OF PROCEDURES FOR THE MEETING OF BOARD OF DIRECTORS AND THE RULES OF PROCEDURES FOR THE MEETING OF SUPERVISORY COMMITTEE
2022-09-08
REVISED PROXY FORM FOR USE AT THE POSTPONED 2022 FIRST CLASS MEETING OF DOMESTIC SHAREHOLDERS
2022-09-08
REVISED PROXY FORM FOR USE AT THE POSTPONED 2022 FIRST CLASS MEETING OF H SHAREHOLDERS
2022-09-08
REVISED PROXY FORM FOR USE AT THE POSTPONED 2022 FIRST EXTRAORDINARY GENERAL MEETING
2022-09-08
SUPPLEMENTAL CIRCULAR IN RELATION TO PROPOSED ISSUE OF A SHARES AND LISTING ON THE SCI-TECH BOARD AND OTHER ANCILLARY RESOLUTIONS, POSTPONEMENT OF THE EGM AND CLASS MEETINGS AND NOTICES OF POSTPONED EGM AND POSTPONED CLASS MEETINGS
2022-09-08
SUPPLEMENTAL NOTICE OF THE POSTPONED 2022 FIRST CLASS MEETING OF DOMESTIC SHAREHOLDERS
2022-09-08
SUPPLEMENTAL NOTICE OF THE POSTPONED 2022 FIRST CLASS MEETING OF H SHAREHOLDERS
2022-09-08
SUPPLEMENTAL NOTICE OF THE POSTPONED 2022 FIRST EXTRAORDINARY GENERAL MEETING
2022-09-08
(1) REVISED INFORMATION IN RESPECT OF THE ISSUE OF A SHARES, (2) POSTPONEMENT OF EGM AND CLASS MEETINGS AND (3) EXTENSION OF CLOSURE OF REGISTER OF MEMBERS FOR THE POSTPONED EGM AND THE POSTPONED CLASS MEETING OF H SHAREHOLDERS
2022-09-05
VOLUNTARY ANNOUNCEMENT INCLUSION OF THE COMPANY AS AN ELIGIBLE STOCK OF THE SHENZHEN-HONG KONG STOCK CONNECT
2022-09-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022
2022-09-01
PROXY FORM FOR USE AT THE 2022 FIRST CLASS MEETING OF DOMESTIC SHAREHOLDERS
2022-09-01
PROXY FORM FOR USE AT THE 2022 FIRST CLASS MEETING OF H SHAREHOLDERS
2022-09-01
PROXY FORM FOR USE AT THE 2022 FIRST EXTRAORDINARY GENERAL MEETING
2022-09-01
(1) PROPOSED ISSUE OF A SHARES AND LISTING ON THE SCI-TECH BOARD AND OTHER ANCILLARY RESOLUTIONS; (2) PROPOSED AMENDMENTS TO THE ARTICLES ANCILLARY TO THE PROPOSED ISSUE OF A SHARES; (3) UNCOVERED DEFICIT OF THE COMPANY AMOUNTING TO MORE THAN ONE-THIRD OF THE TOTAL SHARE CAPITAL OF THE COMPANY; AND (4) NOTICES OF EGM AND CLASS MEETINGS
2022-09-01
NOTICE OF THE 2022 FIRST CLASS MEETING OF DOMESTIC SHAREHOLDERS
2022-09-01
NOTICE OF THE 2022 FIRST CLASS MEETING OF H SHAREHOLDERS
2022-09-01
NOTICE OF THE 2022 FIRST EXTRAORDINARY GENERAL MEETING
2022-09-01
PROPOSED ISSUE OF A SHARES AND LISTING ON THE SCI-TECH BOARD AND OTHER ANCILLARY RESOLUTIONS AND PROPOSED AMENDMENTS TO THE ARTICLES ANCILLARY TO THE PROPOSED ISSUE OF A SHARES AND UNCOVERED DEFICIT OF THE COMPANY AMOUNTING TO MORE THAN ONE-THIRD OF THE TOTAL SHARE CAPITAL OF THE COMPANY
2022-08-25
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022
2022-08-21
VOLUNTARY ANNOUNCEMENT INCLUSION OF THE COMPANY AS A CONSTITUENT STOCK OF HANG SENG INDEX
2022-08-15
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
2022-08-15
NOTICE OF BOARD MEETING
2022-08-02
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022
2022-08-01
CLOSURE OF REGISTER OF MEMBERS FOR THE 2022 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON SEPTEMBER 16, 2022
2022-07-22
INSIDE INFORMATION ANNOUNCEMENT CONDITIONAL MARKETING APPROVAL OBTAINED IN CHINA FOR PUYOUHENG (PUCOTENLIMAB INJECTION) FOR THE TREATMENT IN HIGH LEVELS OF MICROSATELLITE INSTABILITY/DEFICIENT MISMATCH REPAIR (MSI-H/DMMR)
2022-07-04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022
2022-06-21
POLL RESULTS OF THE 2021 ANNUAL GENERAL MEETING HELD ON JUNE 21, 2022
2022-06-01
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
2022-05-27
Proxy Form for the Annual General Meeting to be held on 21 June 2022
2022-05-27
(1) 2021 REPORT OF THE BOARD OF DIRECTORS (2) 2021 REPORT OF THE BOARD OF SUPERVISORS (3) 2021 ANNUAL REPORT (4) 2021 FINANCIAL ACCOUNTS REPORT (5) 2022 FINANCIAL BUDGET (6) 2021 ANNUAL PROFIT DISTRIBUTION PLAN (7) RE-APPOINTMENT OF AUDITOR (8) GENERAL MANDATE TO ISSUE ADDITIONAL SHARES AND NOTICE OF 2021 ANNUAL GENERAL MEETING
2022-05-27
NOTICE OF 2021 ANNUAL GENERAL MEETING
2022-05-27
ARTICLES OF ASSOCIATION
2022-05-27
AMENDMENTS TO THE ARTICLES OF ASSOCIATION
2022-05-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
2022-04-25
CLOSURE OF REGISTER OF MEMBERS FOR ANNUAL GENERAL MEETING TO BE HELD ON JUNE 21, 2022
2022-04-25
2021 Annual Report
2022-04-01
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
2022-03-29
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021
2022-03-22
Next Day Disclosure Return
2022-03-17
PARTIAL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD
2022-03-17
NOTICE OF BOARD MEETING
2022-03-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
2022-02-22
Procedures for Shareholders to Nominate a Person as a Director
2022-02-22
Board Diversity Policy
2022-02-22
Shareholders Communication Policy
2022-02-22
List of Directors and their Roles and Functions
2022-02-22
Terms of Reference for Remuneration and Appraisal Committee
2022-02-22
Terms of Reference for Nomination Committee
2022-02-22
Terms of Reference for Audit Committee
2022-02-22
Articles of Association
2022-02-22
ANNOUNCEMENT OF OFFER PRICE AND ALLOTMENT RESULTS
2022-02-10
GREEN APPLICATION FORM
2022-02-10
GLOBAL OFFERING
2022-02-10
GLOBAL OFFERING
2022-02-03
PHIP (1st submission)
2022-02-03
PHIP (1st submission)
2021-10-29
Application Proof (1st submission)
2021-10-29
Application Proof (1st submission)
Home Page
Company Profile
Strategic Investors
Technical Strength
News Centre
About Us
Company Profile
Milestones
Core Team
Science and Technology
Research Field
Technology Platform
Product Pipeline
Manufacturing Plants
Intellectual Property Rights
Investor Relations
Company Information
Financial Reports
Announcements and Circulars
Corporate Governance
News Centre
Company News
Media Coverage
Join Us
Corporate Culture
Business Outlook
Benefits
Job Opportunities
Contact us
Copyright 2021 By Lepu Biopharma CO.,Ltd.
京公网安备11011702000459号
京ICP备20018649号-1
Home Page
About Us
Science and Technology
Strategic Investors
News Centre
Join Us
Contact Us